Report overview
Travel Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system?s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
This report contains market size and forecasts of Anticholinergic Travel Sickness Drugs in global, including the following market information:
Global Anticholinergic Travel Sickness Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anticholinergic Travel Sickness Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anticholinergic Travel Sickness Drugs companies in 2021 (%)
The global Anticholinergic Travel Sickness Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adults Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anticholinergic Travel Sickness Drugs include GlaxoSmithKline and Baxter International etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anticholinergic Travel Sickness Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticholinergic Travel Sickness Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anticholinergic Travel Sickness Drugs Market Segment Percentages, by Type, 2021 (%)
Adults
Children
Global Anticholinergic Travel Sickness Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anticholinergic Travel Sickness Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drugstores
Other
Global Anticholinergic Travel Sickness Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anticholinergic Travel Sickness Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticholinergic Travel Sickness Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anticholinergic Travel Sickness Drugs revenues share in global market, 2021 (%)
Key companies Anticholinergic Travel Sickness Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anticholinergic Travel Sickness Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Baxter International
